REG - Yourgene Health PLC - Holding(s) in Company

Yourgene HealthAnnouncement

27/01/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230127:nRSa0366Oa&default-theme=true

RNS Number : 0366O  Yourgene Health PLC  27 January 2023

TR-1: Standard form for notification of major holdings

 

 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
 FCA in Microsoft Word format if possible) (i)

 1a. Identity of the issuer or the underlying issuer of existing shares to                                                                                    Yourgene Health plc
 which voting rights are attached (ii):
 1b. Please indicate if the issuer is a non-UK issuer  (please mark with an
 "X" if appropriate)
 Non-UK issuer
 2. Reason for the notification (please mark the appropriate box or boxes with
 an "X")
 An acquisition or disposal of voting rights
 An acquisition or disposal of financial instruments
 An event changing the breakdown of voting rights                                                                                                                                                                                                          X
 Other (please specify) (iii):
 3. Details of person subject to the notification obligation (iv)
 Name                                                                                                                                                         Thermo Fisher Scientific Inc.
 City and country of registered office (if applicable)
 4. Full name of shareholder(s) (if different from 3.) (v)
 Name                                                                                                                                                         Life Technologies Limited
 City and country of registered office (if applicable)
 5. Date on which the threshold was crossed or reached (vi):                                                                                                  11/01/2023
 6. Date on which issuer notified (DD/MM/YYYY):                                                                                                               26/01/2023
 7. Total positions of person(s) subject to the notification obligation
                                                                            % of voting rights attached to shares (total of 8. A)  % of voting rights through financial instruments      Total of both in % (8.A + 8.B)  Total number of voting rights held in issuer (8.A + 8.B) (vii)

(total of 8.B 1 + 8.B 2)
 Resulting situation on the date on which threshold was crossed or reached  Less than 3%                                           Less than 3%                                          Less than 3%                    Less than 3%
 Position of previous notification (if                                      9.01%                                                  11.48%                                                20.85%

 applicable)

 

 8. Notified details of the resulting situation on the date on which the
 threshold was crossed or reached (viii)
 A: Voting rights attached to shares
 Class/type of                                  Number of voting rights (ix)                                                          % of voting rights

shares

 ISIN code (if possible)
                                                Direct                          Indirect                                              Direct                                           Indirect

                                                (DTR5.1)                         (DTR5.2.1)                                           (DTR5.1)                                         (DTR5.2.1)
 GB00BN31ZD89                                   41,356,165                                                                            Less than 3%

 SUBTOTAL 8. A                                  41,356,165                                                                            Less than 3%

 B 1: Financial Instruments according to DTR5.3.1R (1) (a)
 Type of financial instrument                   Expiration  Exercise/                                         Number of voting rights that may be acquired if the instrument is        % of voting rights

date (x)
Conversion Period (xi)

                                                                                                              exercised/converted.

                                                            SUBTOTAL 8. B 1

 B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
 (1) (b)
 Type of financial instrument  Expiration                   Exercise/                               Physical or cash                                          Number of voting rights  % of voting rights

date (x)
Conversion Period (xi)

                                                                                                    Settlement (xii)
 Warrants                      11 December 2023             Exercisable up to 11 December 2023      Physical                                                  20,325,204               Less than 3%
 Warrants                      11 December 2023             Exercisable up to 11 December 2023      Physical                                                  17,094,018               Less than 3%
 Warrants                      11 December 2023             Exercisable up to 11 December 2023      Physical                                                  16,913,319               Less than 3%
                                                                                                    SUBTOTAL 8.B.2                                            54,332,541               Less than 3%

 

 9. Information in relation to the person subject to the notification
 obligation (please mark the

 applicable box with an "X")
 Person subject to the notification obligation is not controlled by any natural
 person or legal entity and does not control any other undertaking(s) holding
 directly or indirectly an interest in the (underlying) issuer (xiii)
 Full chain of controlled undertakings through which the voting rights and/or                                                                                                                                                                 X
 the

financial instruments are effectively held starting with the ultimate
 controlling natural person or legal entity (please add additional rows as
 necessary) (xiv)
 Name (xv)                                       % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                                             than the notifiable threshold
 Thermo Fisher Scientific Inc.                   Less than 3%                                                                Less than 3%                                                                Less than 3%
 Thermo Fisher Scientific Life Holdings Limited  Less than 3%                                                                Less than 3%                                                                Less than 3%
 Life Technologies                               Less than 3%                                                                Less than 3%                                                                Less than 3%

 Limited

 10. In case of proxy voting, please identify:
 Name of the proxy holder
 The number and % of voting rights held
 The date until which the voting rights will be held

 11. Additional information (xvi)

 

 Place of completion  AIM
 Date of completion   26 January 2023

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLBFMJTMTATTRJ